•  
  •  
 

Abstract

Introduction. The correlation between the premenopausal estrogen hormone and estrogen receptors is unknown. The hormone estrogen has a risk factor for causing breast cancer. Meanwhile, the estrogen receptor plays a role in determining further treatment plans in breast cancer patients. Patients with high estrogen receptors have a better prognosis. If the premenopausal estrogen hormone can affect the estrogen-receptor, then the estrogen hormone can be modified to have a better prognosis.

Method. A cross-sectional study enrolled 32 subjects with complete data and was statistically analyzed to find the correlation between premenopausal estrogen hormone and estrogen-receptors.

Results. The estradiol ranged from 15.3 − 89.8 pg/mL, and estrogen receptors showed a range of 10–90%. The Spearman correlation test between the estradiol and the estrogen receptor showed a p-value = 0.864 and a negative correlation coefficient of 0.032.

Conclusion. Estrogen hormone is not statistically associated with estrogen receptors in premenopausal breast cancer patients, thus illustrating that the prognosis of breast cancer is not associated with the estrogen hormone

Included in

Surgery Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.